Statistics for Double optimization of rivastigmine-loaded Nanostructured Lipid Carriers (NLC) for nose-to-brain delivery using the Quality by Design (QbD) approach: formulation variables and instrumental parameters
Total visits
| views | |
|---|---|
| Double optimization of rivastigmine-loaded Nanostructured Lipid Carriers (NLC) for nose-to-brain delivery using the Quality by Design (QbD) approach: formulation variables and instrumental parameters | 338 |
Total visits per month
| views | |
|---|---|
| December 2024 | 13 |
| January 2025 | 4 |
| February 2025 | 10 |
| March 2025 | 3 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
File Visits
| views | |
|---|---|
| Double Optimization of Rivastigmine-Loaded Nanostructured Lipid Carriers (NLC) for Nose-to-Brain Delivery Using the Quality by Design (QbD) Approach.pdf(legacy) | 2 |
Top country views
| views | |
|---|---|
| United States | 211 |
| Germany | 36 |
| Canada | 21 |
| Portugal | 21 |
| Belgium | 15 |
| China | 8 |
| Ireland | 8 |
| United Kingdom | 3 |
| Australia | 2 |
| Brazil | 2 |
| Greece | 2 |
| Sweden | 2 |
| Argentina | 1 |
| France | 1 |
| Indonesia | 1 |
| Japan | 1 |
| Poland | 1 |
| Turkey | 1 |